Does geographical location influence the phenotype of Fabry disease in women in Europe?
This study examines the relationship between phenotype and geographical location of patients with Fabry disease in Europe. Data were taken from patients enrolled in the Fabry Outcome Survey (FOS), as of October 2007. A modified version of the Mainz Severity Score Index (FOS-MSSI) was used to classify patients according to the severity of disease. European patients were grouped depending on country of residence (northern or southern European countries). Results are presented from 762 patients enrolled in FOS in Europe (357 men and 405 women); 66% lived in northern and 34% in southern countries. Median age at onset of symptoms of Fabry disease was similar in both sexes. No differences in disease severity were seen among men, according to place of residence; however, women living in northern countries had higher severity scores (p < 0.001) than those in southern countries. In men and women, FOS-MSSI scores increased with age, irrespective of place of residence. The results suggest that expression of different phenotypic features in Fabry disease in women living in Europe may be influenced by extra-genetic or epigenetic factors. These factors might be related to dietary or environmental influences that differ according to the patient's country of residence.
Barba-Romero
M-A
MA
Internal Medicine Department, Albacete University Hospital, Albacete, Spain. mabarbar@sescam.jccm.es
Deegan
P
P
Giugliani
R
R
Hughes
D
D
D000328:Adult; D000367:Age Factors; D038441:Diet, Mediterranean; D044127:Epigenesis, Genetic; D005060:Europe / Q000453:epidemiology; D000795:Fabry Disease / Q000453:epidemiology* / Q000235:genetics; D005260:Female; D005843:Geography; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D000519:alpha-Galactosidase / Q000235:genetics
D000519:alpha-Galactosidase